Crispr Therapeutics shares owned by Legal & General Group
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Legal & General Group
from 13F filings
Historical chart of Legal & General Group investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Legal & General Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Legal & General Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $4.2M | 67k | 62.60 |
| 2023-09-30 | $3.0M | 67k | 45.39 |
| 2023-06-30 | $3.6M | 64k | 56.14 |
| 2023-03-31 | $2.8M | 61k | 45.23 |
| 2022-12-31 | $2.2M | 55k | 40.65 |
| 2022-09-30 | $3.6M | 54k | 65.32 |
| 2022-06-30 | $3.4M | 55k | 60.77 |
| 2022-03-31 | $3.3M | 53k | 62.73 |
| 2021-12-31 | $3.9M | 52k | 75.75 |
| 2021-09-30 | $5.3M | 48k | 111.94 |
| 2021-06-30 | $5.8M | 36k | 161.89 |
| 2021-03-31 | $4.1M | 33k | 121.86 |
| 2020-12-31 | $4.5M | 29k | 153.13 |
| 2020-09-30 | $2.6M | 31k | 83.72 |
| 2020-06-30 | $1.9M | 26k | 73.47 |
| 2020-03-31 | $538k | 9.1k | 59.26 |
| 2019-12-31 | $2.0M | 34k | 60.27 |
| 2019-09-30 | $44k | 1.1k | 40.55 |
| 2019-06-30 | $51k | 1.1k | 47.00 |
| 2019-03-31 | $19k | 540 | 35.19 |
| 2018-12-31 | $15k | 540 | 27.78 |
| 2018-09-30 | $8.0k | 191 | 41.88 |
| 2018-06-30 | $11k | 191 | 57.59 |